Wuhan Huakang Century Medical Co., Ltd. Share Price

Equities

301235

CNE1000057D4

Construction & Engineering

End-of-day quote Shenzhen S.E. 03:30:00 06/05/2024 am IST 5-day change 1st Jan Change
19.71 CNY +2.50% Intraday chart for Wuhan Huakang Century Medical Co., Ltd. +1.70% -23.10%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 2.64B 366M 30.56B Sales 2025 * 3.69B 511M 42.67B Capitalization 2.08B 288M 24.07B
Net income 2024 * 229M 31.73M 2.65B Net income 2025 * 357M 49.47M 4.13B EV / Sales 2024 * 0.79 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.56 x
P/E ratio 2024 *
9.08 x
P/E ratio 2025 *
5.83 x
Employees 1,342
Yield 2024 *
-
Yield 2025 *
-
Free-Float 43.82%
More Fundamentals * Assessed data
Dynamic Chart
Wuhan Huakang Century Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Wuhan Huakang Century Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Huakang Century Medical Bags Hospital Purification Project for 111.8 Million Yuan; Shares Up 4% MT
Huakang Century Medical's Consortium Bags Hospital Renovation Project for 129.9 Million Yuan MT
Huakang Century Medical Gets Nod to Issue Convertible Bonds MT
Certain A Shares of Wuhan Huakang Century Medical Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-JAN-2024. CI
Huakang Century Medical Consortium Bags 342 Million Yuan Hospital Project MT
Wuhan Huakang Century Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Wuhan Huakang Century Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Wuhan Huakang Century Medical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 20, 2023 CI
Wuhan Huakang Century Medical Co., Ltd. Approves Cash Dividend for 2022 CI
Wuhan Huakang Century Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Wuhan Huakang Century Medical Co., Ltd. Proposes Cash Final Dividend for 2022 CI
Wuhan Huakang Century Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Wuhan Huakang Century Medical Bags Installation Project MT
More news
1 day+2.50%
1 week+1.70%
Current month+2.50%
1 month-11.69%
3 months+24.20%
6 months-24.54%
Current year-23.10%
More quotes
1 week
19.40
Extreme 19.4
19.76
1 month
17.50
Extreme 17.5
22.50
Current year
14.03
Extreme 14.03
26.18
1 year
14.03
Extreme 14.03
36.13
3 years
14.03
Extreme 14.03
68.00
5 years
14.03
Extreme 14.03
68.00
10 years
14.03
Extreme 14.03
68.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 01/12/01
Director of Finance/CFO 44 01/18/01
Chairman 48 01/08/01
Members of the board TitleAgeSince
Chairman 48 01/08/01
Chief Executive Officer 59 01/12/01
Director/Board Member 43 01/14/01
More insiders
Date Price Change Volume
06/24/06 19.71 +2.50% 1,787,231
30/24/30 19.23 -0.77% 1,883,545

End-of-day quote Shenzhen S.E., May 06, 2024

More quotes
Wuhan Huakang Century Medical Co Ltd is a China-based company providing comprehensive services of modern medical purification system. The Company's main products and service categories include medical purification system integration, medical equipment sales, medical consumables sales and operation and maintenance services of medical purification system. The medical purification system integration business is engaged in plane layout planning and design. The medical equipment sales business is mainly engaged in the sales of purchased medical equipment products. The medical consumables sales business is mainly engaged in the distribution of low value consumables, high value consumables and in vitro diagnostic reagents. The operation and maintenance services of medical purification system mainly include the repair, maintenance, upgrading and transformation of medical purification equipment, disinfection and sterilization of air conditioning system and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
19.71
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 301235 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW